GSK plc provides an update on the CALM-1 and CALM-2 phase III clinical trials, which assessed the efficacy and safety of two doses of camlipixant (a P2X3 receptor antagonist) in adults with refractory ...
The acquisition, which involves a concurrent licensing deal with startup Mirador, gives Jasper a chance to rebound from ...
Morning Overview on MSN
China’s Tianwen-2 reached an asteroid that may be a broken-off piece of the moon
China’s Tianwen-2 spacecraft has closed to within approximately 20 kilometers of asteroid 469219 Kamoʻoalewa, a small body ...
A key goal of the redesigned scheme is to lift homegrown smartphone makers, who have lost ground even as manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results